NCT04166357

Brief Summary

Neuromuscular US will be a good and non invasive predictor for respiratory and autonomic dysfunctions in GBS through evaluation of diaphragmatic thickness, phrenic and vagus nerve cross sectional area.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 12, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 18, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
Last Updated

November 18, 2019

Status Verified

November 1, 2019

Enrollment Period

1 year

First QC Date

November 12, 2019

Last Update Submit

November 15, 2019

Conditions

Keywords

Guillain Barre Syndrome, neuromuscular ultrasound

Outcome Measures

Primary Outcomes (1)

  • Neuromuscular ultrasound

    Sensitivity and specificity of US in predicting respiratory and autonomic complications in Guillain Barre Syndrome

    24-48 hours

Secondary Outcomes (2)

  • Respiratory and autonomic complications

    1 month

  • Correlation between clinical scores and reference US values

    48-72 hours

Study Arms (1)

Respiratory and autonomic complications of GBS

Early detection of respiratory failure is among the main challenges raised by the management of GBS. Careful monitoring by an experienced team of nurses and physicians is crucial. The classic signs of respiratory failure occur late, and the early manifestations consist only of tachypnea, tachycardia, air hunger, broken sentences, and a need to pause between sentences; later, use of the accessory respiratory muscles, paradoxical breathing, and orthopnea indicate severe diaphragmatic weakness. Autonomic dysfunction occurred in the affected patients, including cardiac arrhythmia, hypertension or hypotension, ileus, and urinary retention.

Diagnostic Test: neuromuscular ultrasound

Interventions

Neuromuscular ultrasound refers to a field in medicine in which ultrasound is used to diagnosis and guide treatment for people with neuromuscular diseases. Neuromuscular ultrasound is often combined with electrodiagnosis, and particularly nerve conduction studies and EMG, to improve the accuracy of diagnosis and add anatomic information to the functional information obtained with electrodiagnosis. It has been demonstrated that neuromuscular ultrasound adds value to the diagnosis of nerve disease in over 80% of cases.

Respiratory and autonomic complications of GBS

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

100 Patients that will fulfill the published diagnostic criteria of GBS.

You may qualify if:

  • Patients that will fulfill the published diagnostic criteria of GBS.
  • Age: 18-65
  • Both sexes

You may not qualify if:

  • History of cardiopulmonary dysfunction
  • BMI\>30 Kg/m2
  • Renal or hepatic failure
  • Sepsis
  • Autonomic or respiratory dysfunction from the start
  • Patients with hypo- or hyperkalemic paralysis, porphyria, viral myositis, botulism, diphtheritic neuropathy, and history of potential toxic exposure were excluded.
  • Abnormal pulmonary function test from the start.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University Hospital

Al Mansurah, Egypt

RECRUITING

MeSH Terms

Conditions

Guillain-Barre Syndrome

Condition Hierarchy (Ancestors)

PolyradiculoneuropathyAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesPolyneuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesAutoimmune DiseasesImmune System DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Esmael M Ahmed, MD

    Assistant Prof of Neurology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Esmael M Ahmed, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Prof of Neurology

Study Record Dates

First Submitted

November 12, 2019

First Posted

November 18, 2019

Study Start

July 1, 2019

Primary Completion

July 1, 2020

Study Completion

November 1, 2020

Last Updated

November 18, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations